Skip to main content

and
  1. Article

    Open Access

    Metformin treatment is associated with improved outcome in patients with diabetes and advanced heart failure (HFrEF)

    The role of metformin (MET) in the treatment of patients with advanced HFrEF and type 2 diabetes mellitus (DM) is not firmly established. We studied the impact of MET on metabolic profile, quality of life (QoL...

    Jan Benes, Martin Kotrc, Katerina Kroupova, Peter Wohlfahrt in Scientific Reports (2022)

  2. Article

    Open Access

    FGF-23 is a biomarker of RV dysfunction and congestion in patients with HFrEF

    There is no biomarker reflecting right ventricular dysfunction in HFrEF patients used in clinical practice. We have aimed to look for a circulating marker of RV dysfunction employing a quantitative proteomic s...

    Jan Benes, Katerina Kroupova, Martin Kotrc, Jiri Petrak, Petr Jarolim in Scientific Reports (2023)